Invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
in	O
renal	O
transplant	I:C0022671
patients	O
:	O
a	O
single	O
center	I:C0242481
study	I:C0242481
.	O

Invasive	O
fungal	I:C1262313
infections	I:C1262313
in	O
renal	B:C0022671
transplant	I:C0022671
patients	O
:	O
a	O
single	O
center	I:C0242481
study	I:C0242481
.	O

Invasive	O
fungal	I:C1262313
infections	I:C1262313
in	O
renal	O
transplant	I:C0022671
patients	O
:	O
a	O
single	B:C0242481
center	I:C0242481
study	I:C0242481
.	O

Timely	O
diagnosis	B:C0011900
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	B:C0022671
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	B:C0022671
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	B:C0021079
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	O
.	O

Timely	O
diagnosis	O
of	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
(	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
)	O
in	O
renal	O
transplant	I:C0022671
(	O
renal	O
transplant	I:C0022671
)	O
patients	O
on	O
immunosuppression	O
is	O
often	O
difficult	O
,	O
jeopardizing	O
their	O
life	O
and	O
graft	B:C0332835
.	O

We	O
reported	O
invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
and	O
their	O
causative	O
fungal	I:C0449411
agents	I:C0449411
in	O
post-	O
renal	O
transplant	I:C0022671
patients	O
.	O

We	O
reported	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
and	O
their	O
causative	B:C0449411
fungal	I:C0449411
agents	I:C0449411
in	O
post-	O
renal	O
transplant	I:C0022671
patients	O
.	O

We	O
reported	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
and	O
their	O
causative	O
fungal	I:C0449411
agents	I:C0449411
in	O
post-	O
renal	B:C0022671
transplant	I:C0022671
patients	O
.	O

This	O
was	O
a	O
retrospective	O
6	O
-	O
year	O
clinical	B:C0008972
study	I:C0008972
carried	O
out	O
from	O
2010	O
to	O
2015	O
on	O
1900	O
renal	O
transplant	I:C0022671
patients	O
.	O

This	O
was	O
a	O
retrospective	O
6	O
-	O
year	O
clinical	O
study	I:C0008972
carried	O
out	O
from	O
2010	O
to	O
2015	O
on	O
1900	O
renal	B:C0022671
transplant	I:C0022671
patients	O
.	O

Clinical	B:C1516606
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	O
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	B:C0040288
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	O
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	B:C3714514
,	O
risk	O
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	B:C0035648
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	O
factors	I:C0035648
and	O
graft	B:C0877382
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	O
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	B:C0201976
creatinine	I:C0201976
(	O
serum	O
creatinine	I:C0201976
)	O
.	O

Clinical	O
data	I:C1516606
included	O
patient	O
-	O
donor	O
demographics	O
,	O
time	O
to	O
onset	O
of	O
infection	O
,	O
risk	O
factors	I:C0035648
and	O
graft	O
function	I:C0877382
in	O
terms	O
of	O
serum	O
creatinine	I:C0201976
(	O
serum	B:C0201976
creatinine	I:C0201976
)	O
.	O

To	O
identify	O
invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	O
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	B:C1535502
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	O
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	B:C1535502
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	O
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	B:C0005767
,	O
tissue	O
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	B:C0040300
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	O
,	O
and	O
wound	B:C0438733
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	O
methods	I:C0085127
.	O

To	O
identify	O
invasive	O
fungal	I:C1262313
infections	I:C1262313
,	O
we	O
examined	O
bronchoalveolar	O
lavage	I:C1535502
(	O
bronchoalveolar	O
lavage	I:C1535502
)	O
,	O
blood	O
,	O
tissue	O
,	O
and	O
wound	O
swab	I:C0438733
samples	I:C0438733
by	O
conventional	O
mycological	B:C0085127
methods	I:C0085127
.	O

invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
were	O
diagnosed	O
in	O
30	O
(	O
1.56	O
%	O
)	O
patients	O
on	O
triple	O
immunosuppression	I:C0021079
,	O
mainly	O
males	O
(	O
n	O
=	O
25	O
)	O
with	O
mean	O
age	I:C1834001
of	O
36.57	O
±	O
11.9	O
years	O
at	O
13.12	O
±	O
18.35	O
months	O
post-	O
renal	O
transplant	I:C0022671
.	O

invasive	O
fungal	I:C1262313
infections	I:C1262313
were	O
diagnosed	B:C0011900
in	O
30	O
(	O
1.56	O
%	O
)	O
patients	O
on	O
triple	O
immunosuppression	I:C0021079
,	O
mainly	O
males	O
(	O
n	O
=	O
25	O
)	O
with	O
mean	O
age	I:C1834001
of	O
36.57	O
±	O
11.9	O
years	O
at	O
13.12	O
±	O
18.35	O
months	O
post-	O
renal	O
transplant	I:C0022671
.	O

invasive	O
fungal	I:C1262313
infections	I:C1262313
were	O
diagnosed	O
in	O
30	O
(	O
1.56	O
%	O
)	O
patients	O
on	O
triple	B:C0021079
immunosuppression	I:C0021079
,	O
mainly	O
males	O
(	O
n	O
=	O
25	O
)	O
with	O
mean	O
age	I:C1834001
of	O
36.57	O
±	O
11.9	O
years	O
at	O
13.12	O
±	O
18.35	O
months	O
post-	O
renal	O
transplant	I:C0022671
.	O

invasive	O
fungal	I:C1262313
infections	I:C1262313
were	O
diagnosed	O
in	O
30	O
(	O
1.56	O
%	O
)	O
patients	O
on	O
triple	O
immunosuppression	I:C0021079
,	O
mainly	O
males	O
(	O
n	O
=	O
25	O
)	O
with	O
mean	B:C1834001
age	I:C1834001
of	O
36.57	O
±	O
11.9	O
years	O
at	O
13.12	O
±	O
18.35	O
months	O
post-	O
renal	O
transplant	I:C0022671
.	O

invasive	O
fungal	I:C1262313
infections	I:C1262313
were	O
diagnosed	O
in	O
30	O
(	O
1.56	O
%	O
)	O
patients	O
on	O
triple	O
immunosuppression	I:C0021079
,	O
mainly	O
males	O
(	O
n	O
=	O
25	O
)	O
with	O
mean	O
age	I:C1834001
of	O
36.57	O
±	O
11.9	O
years	O
at	O
13.12	O
±	O
18.35	O
months	O
post-	O
renal	B:C0022671
transplant	I:C0022671
.	O

Aspergillus	B:C0004034
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	B:C1535502
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	B:C0040300
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	B:C0438733
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	B:C0332835
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	B:C0006837
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	B:C1535502
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	B:C0005767
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	B:C0438733
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	B:C1292533
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	B:C0332835
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	B:C0026716
in	O
bronchoalveolar	O
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Aspergillus	O
species	I:C0004034
was	O
identified	O
in	O
11	O
bronchoalveolar	O
lavage	I:C1535502
,	O
one	O
tissue	O
,	O
and	O
one	O
wound	O
specimen	I:C0438733
each	O
,	O
30.76	O
%	O
of	O
these	O
were	O
fatal	O
and	O
15.38	O
%	O
caused	O
graft	O
loss	O
;	O
Candida	O
albicans	I:C0006837
was	O
in	O
nine	O
bronchoalveolar	O
lavage	I:C1535502
,	O
four	O
blood	O
,	O
two	O
wound	O
swab	I:C0438733
,	O
and	O
one	O
tissue	O
specimens	I:C1292533
,	O
25	O
%	O
of	O
these	O
were	O
fatal	O
and	O
25	O
%	O
had	O
graft	O
loss	O
and	O
one	O
mucor	O
in	O
bronchoalveolar	B:C1535502
lavage	I:C1535502
which	O
was	O
fatal	O
.	O

Seven	O
patients	O
were	O
diabetic	B:C0241863
,	O
10	O
had	O
superadded	O
cytomegalovirus	O
infection	I:C0010823
,	O
and	O
15	O
were	O
anti-rejected	O
.	O

Seven	O
patients	O
were	O
diabetic	O
,	O
10	O
had	O
superadded	O
cytomegalovirus	B:C0010823
infection	I:C0010823
,	O
and	O
15	O
were	O
anti-rejected	O
.	O

Seven	O
patients	O
were	O
diabetic	O
,	O
10	O
had	O
superadded	O
cytomegalovirus	O
infection	I:C0010823
,	O
and	O
15	O
were	O
anti-rejected	B:C0021079
.	O

invasive	B:C1262313
fungal	I:C1262313
infections	I:C1262313
are	O
associated	O
with	O
increased	O
morbidity	O
and	O
mortality	O
in	O
renal	O
transplant	I:C0022671
patients	O
.	O

invasive	O
fungal	I:C1262313
infections	I:C1262313
are	O
associated	O
with	O
increased	O
morbidity	O
and	O
mortality	O
in	O
renal	B:C0022671
transplant	I:C0022671
patients	O
.	O

Triple	B:C0021079
immunosuppression	I:C0021079
,	O
broad	O
spectrum	I:C0003232
antibiotics	I:C0003232
for	O
≥	O
two	O
weeks	O
,	O
diabetes	O
and	O
superadded	O
infection	I:C0038826
are	O
added	O
risks	O
for	O
these	O
patients	O
.	O

Triple	O
immunosuppression	I:C0021079
,	O
broad	B:C0003232
spectrum	I:C0003232
antibiotics	I:C0003232
for	O
≥	O
two	O
weeks	O
,	O
diabetes	O
and	O
superadded	O
infection	I:C0038826
are	O
added	O
risks	O
for	O
these	O
patients	O
.	O

Triple	O
immunosuppression	I:C0021079
,	O
broad	O
spectrum	I:C0003232
antibiotics	I:C0003232
for	O
≥	O
two	O
weeks	O
,	O
diabetes	B:C0011847
and	O
superadded	O
infection	I:C0038826
are	O
added	O
risks	O
for	O
these	O
patients	O
.	O

Triple	O
immunosuppression	I:C0021079
,	O
broad	O
spectrum	I:C0003232
antibiotics	I:C0003232
for	O
≥	O
two	O
weeks	O
,	O
diabetes	O
and	O
superadded	B:C0038826
infection	I:C0038826
are	O
added	O
risks	O
for	O
these	O
patients	O
.	O

Prevention	O
,	O
early	O
diagnosis	B:C0011900
,	O
and	O
appropriate	O
management	O
are	O
necessary	O
to	O
improve	O
their	O
prognosis	O
.	O

Prevention	O
,	O
early	O
diagnosis	O
,	O
and	O
appropriate	O
management	O
are	O
necessary	O
to	O
improve	O
their	O
prognosis	B:C0033325
.	O

